by Jordana Choucair | Sep 26, 2022 | D.C. News
The Biden administration is set to launch a private refugee sponsorship program this Fall that will enlist private organizations and groups of everyday Americans to sponsor and resettle refugees. The program would first draw from the existing refugee pipeline –...
by Jordana Choucair | Sep 26, 2022 | Life Sciences
Moderna announced that it asked the Food and Drug Administration (FDA) to authorize its omicron booster shots for children. Moderna filed two separate FDA authorization requests, one for adolescents ages 12 to 17 and another for kids ages 6 to 11. The biotech company...
by Jordana Choucair | Sep 26, 2022 | Opioid/Substance Use Disorders
A FAIR Health analysis – released to Axios one day in advance of publication – shows the rising burden of substance use across the U.S. According to the study of private insurance claims, 42 states saw an increase in the proportion of patients with opioid and...
by Jordana Choucair | Sep 26, 2022 | Providers
A New York Times (NYT) investigation found that many of the country’s largest nonprofit hospital systems have drifted far from their charitable roots. According to the NYT analysis, more than half of all hospitals in the U.S. are set up as nonprofit, a designation...
by Jordana Choucair | Sep 26, 2022 | Opioid/Substance Use Disorders
President Biden announced that his administration will distribute $1.5 billion to states and territories to fund responses to opioid overdoses and support recovery. The U.S. Department of Health and Human Services (HHS) will disseminate the funding through the...
by Jordana Choucair | Sep 23, 2022 | Life Sciences
Senate and House health committee leaders reached an agreement on a five-year reauthorization of the Food and Drug Administration’s (FDA) user fee. The renewal will be part of the short-term continuing resolution, which Congress must pass by October 1 to avoid a...
Recent Comments